Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

ATXIATXI
21 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in Avenue Therapeutics, Inc.

GEODE CAPITAL MANAGEMENT, LLC previously held 0 shares of ATXI (Avenue Therapeutics, Inc.), worth $0 as of 2024-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$427,000

Total Shares Change

-67,798

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%$3.50
0
2024-Q1
Unchanged
52,160
0.0%
$7,6930.0%$11.06
0
2023-Q4
Decreased
52,160
-0.8%
$8,4760.0%$12.07
0
2023-Q3
Unchanged
52,571
0.0%
$36,9990.0%$53.03
0
2023-Q2
Increased
52,571
+359.9%
$60,4560.0%$85.13
23
2023-Q1
Decreased
11,430
-0.9%
$13,3730.0%$82.50
0
2022-Q4
New
11,534
-
$13,0000.0%$87.00
27
2022-Q3
Exited
0
-100.0%
$00.0%$543.75
0
2022-Q2
Unchanged
84,033
0.0%
$22,0000.0%$363.94
0
2022-Q1
Increased
84,033
+8.6%
$40,0000.0%$578.02
15
2021-Q4
Decreased
77,413
-8.2%
$70,0000.0%$991.13
0
2021-Q3
Increased
84,346
+6.0%
$125,0000.0%$1,665.00
16
2021-Q2
Decreased
79,556
-40.0%
$199,0000.0%$2,823.75
0
2021-Q1
Increased
132,594
+5.8%
$804,0000.0%$6,468.75
26
2020-Q4
Increased
125,261
+7.0%
$745,0000.0%$6,525.00
26
2020-Q3
Increased
117,036
+0.2%
$1.3M0.0%$12,262.50
25
2020-Q2
Increased
116,827
+66.6%
$1.3M0.0%$12,465.00
37
2020-Q1
Increased
70,115
+3.3%
$626,0000.0%$9,461.25
25
2019-Q4
Increased
67,911
+0.2%
$651,0000.0%$10,552.50
24
2019-Q3
Unchanged
67,798
0.0%
$404,0000.0%$6,547.50
0
2019-Q2
New
67,798
-
$427,0000.0%$7,087.50
33

Other major holders of ATXI: RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used